Lipoprotein receptor-related protein-6 protects the brain from ischemic injury

Stroke. 2013 Aug;44(8):2284-2291. doi: 10.1161/STROKEAHA.113.001320. Epub 2013 Jun 6.

Abstract

Background and purpose: Loss-of-function mutations of the lipoprotein receptor-related protein-6 (LRP6), a coreceptor in the Wingless-related integration site-β-catenin prosurvival pathway, have been implicated in myocardial ischemia and neurodegeneration. However, it remains to be established whether LRP6 is also involved in ischemic brain injury. We used LRP6+/- mice to examine the role of this receptor in the mechanisms of focal cerebral ischemia.

Methods: Focal cerebral ischemia was induced by transient occlusion of the middle cerebral artery. Motor deficits and infarct volume were assessed 3 days later. Glycogen-synthase-kinase-3β (GSK-3β) phosphorylation was examined by Western blotting with phosphospecific antibodies, and the mitochondrial membrane potential changes induced by Ca2+ were also assessed.

Results: LRP6+/- mice have larger stroke and more severe motor deficits, effects that were independent of intraischemic cerebral blood flow, vascular factors, or cytosolic β-catenin levels. Rather, LRP6 haploinsufficiency increased the activating phosphorylation and decreased the inhibitory phosphorylation of GSK-3β, a kinase involved in proinflammatory signaling and mitochondrial dysfunction. Accordingly, postischemic inflammatory gene expression was enhanced in LRP6+/- mice. Furthermore, the association of mitochondria with activated GSK-3β was increased in LRP6+/- mice, resulting in a reduction in the Ca2+ handling ability of mitochondria. The mitochondrial dysfunction was reversed by pharmacological inhibition of GSK-3β.

Conclusions: LRP6 activates an endogenous neuroprotective pathway that acts independently of β-catenin by controlling GSK-3β activity and preventing its deleterious mitochondrial and proinflammatory effects. The findings raise the possibility that emerging treatment strategies for diseases attributable to LRP6 loss-of-function mutations could also lead to new therapeutic avenues for ischemic stroke.

Keywords: Wnt signaling pathway; cerebral ischemia; glycogen-synthase-kinase-3; mitochondria; stroke.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Behavior, Animal / physiology
  • Brain / metabolism*
  • Brain / pathology*
  • Brain / physiopathology
  • Brain Ischemia / genetics
  • Brain Ischemia / pathology
  • Brain Ischemia / prevention & control*
  • Glycogen Synthase Kinase 3 / metabolism
  • Glycogen Synthase Kinase 3 beta
  • Inflammation / genetics
  • Inflammation / metabolism
  • Inflammation / prevention & control
  • Low Density Lipoprotein Receptor-Related Protein-6 / deficiency
  • Low Density Lipoprotein Receptor-Related Protein-6 / physiology*
  • Mice
  • Mitochondria / genetics
  • Motor Activity / genetics
  • Phosphorylation / genetics
  • Signal Transduction / genetics
  • beta Catenin / genetics
  • beta Catenin / metabolism
  • beta Catenin / physiology

Substances

  • Low Density Lipoprotein Receptor-Related Protein-6
  • beta Catenin
  • Glycogen Synthase Kinase 3 beta
  • Gsk3b protein, mouse
  • Glycogen Synthase Kinase 3